Leafcutter ants live in highly organized colonies where every ant has a job, and now researchers can flip those jobs like a switch. By manipulating just two neuropeptides, scientists can turn ...
Washington — The White House asked Congress on Wednesday for $1 billion to boost the pensions of workers at former General Motors auto parts unit Delphi that were cut during the Detroit automaker's ...
Once again, there is a chance Congress could ride to the much-belated rescue of the surviving nonunion retirees of Delphi Corp. − a once-giant Michigan-based auto supplier created by General Motors – ...
The module <NameOfSystemFile> failed to load. Make sure the binary is sorted at the specified path or debug it to check for problems with the binary or dependent .DLL ...
Add Yahoo as a preferred source to see more of our stories on Google. Modern glaucoma treatments can only preserve a patient's current level of vision, offering no hope of restoration. A new Phase 1 ...
Modern glaucoma treatments can only preserve a patient’s current level of vision, offering no hope of restoration. A new Phase 1 clinical trial is using gene therapy that could turn back the clock on ...
A newly discovered molecule, OLE, restored the brain's immune cells to a more protective state in Alzheimer's disease models. The treatment reduced the accumulation of toxic plaques and improved ...
A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s models. The treatment reduced toxic plaque buildup and improved memory, raising ...
If a Fault Module Name Kernelbase.dll is causing application crashes on your Windows 11/10 computer, then this post may be able to help you. KernelBase.dll is a Dynamic Link Library file in the ...
Have you ever given much thought to the subconscious mind? Until recently, I hadn’t. I thought it was a Freudian concept, or something nebulous to do with dreams. Now, my wellness-skewed algorithm ...
Here’s what you’ll learn when you read this story: Modern glaucoma treatments can only preserve a patient’s current level of vision, offering no hope of restoration. A new Phase 1 clinical trial is ...